Table 3 Comparative analysis of various factors between Non recurrent hemorrhage and recurrent hemorrhage groups after vitrectomy
|  | No (N = 547) | Yes (N = 29) | P value |
|---|---|---|---|
Eye | Â | Â | 0.209 |
 OD | 274 (50.1%) | 18 (62.1%) |  |
 OS | 273 (49.9%) | 11 (37.9%) |  |
Sex | Â | Â | 0.580 |
 Female | 236 (43.1%) | 11 (37.9%) |  |
 Male | 311 (56.9%) | 18 (62.1%) |  |
Transpupillary thermotherapy |  | < 0.001 | |
 No | 31 (5.7%) | 27 (93.1%) |  |
 Yes | 516 (94.3%) | 2 (6.9%) |  |
Drug | Â | Â | 0.004 |
 Aflibercept | 235 (43.0%) | 4 (13.8%) |  |
 Lucentis | 290 (53.0%) | 22 (75.9%) |  |
 None | 22 (4.0%) | 3 (10.3%) |  |
Cardiovascular disease |  | < 0.001 | |
 No | 483 (88.3%) | 19 (65.5%) |  |
 Yes | 64 (11.7%) | 10 (34.5%) |  |
Cerebrovascular disease |  | < 0.001 | |
 No | 473 (86.5%) | 13 (44.8%) |  |
 Yes | 74 (13.5%) | 16 (55.2%) |  |
Cataract | Â | Â | 0.282 |
 No | 246 (45.0%) | 16 (55.2%) |  |
 Yes | 301 (55.0%) | 13 (44.8%) |  |
Anticoagulants |  |  | < 0.001 |
 No | 425 (77.7%) | 5 (17.2%) |  |
 Yes | 122 (22.3%) | 24 (82.8%) |  |
Filling |  |  | < 0.001 |
 Gas | 27 (4.9%) | 19 (65.5%) |  |
 Silicon oil | 390 (71.3%) | 2 (6.9%) |  |
 Water | 130 (23.8%) | 8 (27.6%) |  |
Smoking | Â | Â | 0.004 |
 No | 241 (44.1%) | 5 (17.2%) |  |
 Yes | 306 (55.9%) | 24 (82.8%) |  |
Age (years) | Â | Â | 0.024 |
 Mean (SD) | 55.428 (11.090) | 60.172 (8.401) |  |
 Range | 15.000–84.000 | 40.000–72.000 |  |
Diabetic duration (years) | Â | Â | 0.070 |
 Mean (SD) | 14.106 (6.475) | 11.862 (6.507) |  |
 Range | 1.000–25.000 | 4.000–25.000 |  |
DR grade | Â | Â | 0.027 |
 4 | 141 (25.8%) | 9 (31.0%) |  |
 5 | 268 (49.0%) | 19 (65.5%) |  |
 6 | 138 (25.2%) | 1 (3.4%) |  |
Glucose pre (mmol/L) | Â | Â | 0.372 |
 Mean (SD) | 6.007 (1.167) | 6.207 (1.214) |  |
 Range | 3.840–7.990 | 4.170–7.990 |  |
Glycated hemoglobin (%) |  |  | < 0.001 |
 Mean (SD) | 8.078 (1.116) | 10.102 (0.608) |  |
 Range | 6.000–10.930 | 7.750–10.850 |  |
BMI (kg/m2) |  |  | < 0.001 |
 Mean (SD) | 25.144 (1.258) | 26.260 (1.313) |  |
 Range | 23.000–30.500 | 23.310–28.740 |  |
Systolic blood pressure (mmHg) | Â | 0.020 | |
 Mean (SD) | 158.821 (16.300) | 166.207 (21.483) |  |
 Range | 130.000–199.000 | 127.000–198.000 |  |
Diastolic blood pressure (mmHg) | Â | 0.897 | |
 Mean (SD) | 96.698 (7.288) | 96.517 (8.288) |  |
 Range | 70.000–110.000 | 85.000–110.000 |  |
Surgical time (minutes) | Â | Â | 0.044 |
 Mean (SD) | 107.088 (22.104) | 98.655 (19.104) |  |
 Range | 61.000–155.000 | 65.000–140.000 |  |
IOP pre (mmHg) | Â | Â | 0.122 |
 Mean (SD) | 15.331 (3.537) | 16.379 (3.793) |  |
 Range | 10.000–21.000 | 10.000–21.000 |  |
IOP at 3 days (mmHg) | Â | Â | 0.814 |
 Mean (SD) | 15.903 (4.005) | 15.724 (3.442) |  |
 Range | 10.000–29.000 | 11.000–21.000 |  |
IOP at 15 days (mmHg) | Â | Â | 0.683 |
 Mean (SD) | 15.612 (3.432) | 15.345 (3.498) |  |
 Range | 10.000–24.000 | 10.000–21.000 |  |
IOP at 45 days (mmHg) | Â | Â | 0.098 |
 Mean (SD) | 15.729 (3.594) | 14.586 (4.128) |  |
 Range | 10.000–30.000 | 10.000–25.000 |  |
IOP at 90 days (mmHg) | Â | Â | 0.632 |
 Mean (SD) | 16.062 (4.626) | 16.483 (4.085) |  |
 Range | 10.000–42.000 | 10.000–31.000 |  |